In a letter to Dr Thomas (NIBSC), Pat Thomas (Hoechst) indicated that Hoechst intended to introduce Haemate P to the market, approximately two years after obtaining a product licence.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates